Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | September 04, 2024 |
| PDB ID ▲ | UniProt ID | Title | Descriptor |
|---|---|---|---|
| 8V0X | P0DTC2 | SARS-CoV-2 Omicron-EG.5 3-RBD down Spike Protein Trimer 3 (S-GSAS-Omicron-EG.5) | |
| 8V1F | O15393 | TMPRSS2 complexed with the noncovalent inhibitor 6-amidino-2-napthol | |
| 8V2E | 8V2E | Crystal structure of B055 scaffold boost immunogen in complex with a mature 10E8 Fab | |
| 8V4S | Q64663 | Cryo-EM structure of the rat P2X7 receptor in the apo closed state purified in the absence of sodium | |
| 8V5K | T1UCV5 | Structure of the Human Respirovirus 3 Fusion Protein Bound to Camelid Nanobodies 4C03 and 4C06 | |
| 8V5K | 8V5K | Structure of the Human Respirovirus 3 Fusion Protein Bound to Camelid Nanobodies 4C03 and 4C06 | |
| 8V80 | P0ABE7 | Alpha7-nicotinic acetylcholine receptor bound to epibatidine and (-)-TQS | |
| 8V80 | P36544 | Alpha7-nicotinic acetylcholine receptor bound to epibatidine and (-)-TQS | |
| 8V82 | P0ABE7 | Alpha7-nicotinic acetylcholine receptor bound to epibatidine and PNU-120596 | |
| 8V82 | P36544 | Alpha7-nicotinic acetylcholine receptor bound to epibatidine and PNU-120596 | |
| 8V86 | P0ABE7 | Alpha7-nicotinic acetylcholine receptor bound to GAT107 | |
| 8V86 | P36544 | Alpha7-nicotinic acetylcholine receptor bound to GAT107 | |
| 8V88 | P0ABE7 | Alpha7-nicotinic acetylcholine receptor bound to epibatidine and GAT107 | |
| 8V88 | P36544 | Alpha7-nicotinic acetylcholine receptor bound to epibatidine and GAT107 | |
| 8V89 | P0ABE7 | Alpha7-nicotinic acetylcholine receptor time resolved resting state | |
| 8V89 | P36544 | Alpha7-nicotinic acetylcholine receptor time resolved resting state | |
| 8V8A | P0ABE7 | Alpha7-nicotinic acetylcholine receptor time resolved bound to epibatidine and PNU-120596 desensitized intermediate state | |
| 8V8A | P36544 | Alpha7-nicotinic acetylcholine receptor time resolved bound to epibatidine and PNU-120596 desensitized intermediate state | |
| 8V8C | P0ABE7 | Alpha7-nicotinic acetylcholine receptor time resolved bound to epibatidine and PNU-120596 asymmetric state 1 | |
| 8V8C | P36544 | Alpha7-nicotinic acetylcholine receptor time resolved bound to epibatidine and PNU-120596 asymmetric state 1 | |
| 8V8D | P0ABE7 | Alpha7-nicotinic acetylcholine receptor time resolved bound to epibatidine and PNU-120596 asymmetric state 2 | |
| 8V8D | P36544 | Alpha7-nicotinic acetylcholine receptor time resolved bound to epibatidine and PNU-120596 asymmetric state 2 | |
| 8V9Q | O08912 | Crystal structure of mGalNAc-T1 in complex with the mucin glycopeptide Muc5AC-13, Mn2+, and UDP. | |
| 8V9Q | P98088 | Crystal structure of mGalNAc-T1 in complex with the mucin glycopeptide Muc5AC-13, Mn2+, and UDP. | |
| 8VAO | P0DTC2 | Simulation-driven design of prefusion stabilized SARS-CoV-2 spike S2 antigen | |
| 8VBY | Q01959 | Structure of the human dopamine transporter in complex with beta-CFT, MRS7292 and divalent zinc | |
| 8VCC | 8VCC | Crystal structure of H19 influenza A virus hemagglutinin from A/lesser scaup/California/3087/2010 | |
| 8VCR | P0DTC2 | SARS-CoV-2 Spike S2 bound to Fab 54043-5 | |
| 8VCR | 8VCR | SARS-CoV-2 Spike S2 bound to Fab 54043-5 | |
| 8VCX | Q30069 | Human TCR A2.13 in complex with DQ8-InsCpep | |
| 8VCX | O19707 | Human TCR A2.13 in complex with DQ8-InsCpep | |
| 8VCX | P01308 | Human TCR A2.13 in complex with DQ8-InsCpep | |
| 8VCX | 8VCX | Human TCR A2.13 in complex with DQ8-InsCpep | |
| 8VCY | Q30069 | Human TCR A2.13 in complex with DQ8-InsC8-15NPY | |
| 8VCY | O19707 | Human TCR A2.13 in complex with DQ8-InsC8-15NPY | |
| 8VCY | 8VCY | Human TCR A2.13 in complex with DQ8-InsC8-15NPY | |
| 8VD0 | Q30069 | Human TCR ET650-4 in complex with DQ8-InsC8-15-IAPP2 | |
| 8VD0 | O19707 | Human TCR ET650-4 in complex with DQ8-InsC8-15-IAPP2 | |
| 8VD0 | 8VD0 | Human TCR ET650-4 in complex with DQ8-InsC8-15-IAPP2 | |
| 8VD0 | O19707 | Human TCR ET650-4 in complex with DQ8-InsC8-15-IAPP2 | |
| 8VD0 | 8VD0 | Human TCR ET650-4 in complex with DQ8-InsC8-15-IAPP2 | |
| 8VD2 | Q30069 | Human TCR ET650-4 in complex with DQ8-InsC8-15-IAPP1 | |
| 8VD2 | O19707 | Human TCR ET650-4 in complex with DQ8-InsC8-15-IAPP1 | |
| 8VD2 | 8VD2 | Human TCR ET650-4 in complex with DQ8-InsC8-15-IAPP1 | |
| 8VDD | Q30069 | Crystal structure of Proinsulin C-peptide bound to HLA-DQ8 | |
| 8VDD | O19707 | Crystal structure of Proinsulin C-peptide bound to HLA-DQ8 | |
| 8VDD | P01308 | Crystal structure of Proinsulin C-peptide bound to HLA-DQ8 | |
| 8VDU | Q30069 | Crystal structure of hybrid insulin peptide (InsC8-15-IAPP74-80) bound to HLA-DQ8 | |
| 8VDU | O19707 | Crystal structure of hybrid insulin peptide (InsC8-15-IAPP74-80) bound to HLA-DQ8 | |
| 8VDU | 8VDU | Crystal structure of hybrid insulin peptide (InsC8-15-IAPP74-80) bound to HLA-DQ8 |
